-
1
-
-
51649166119
-
Zur statistischen Analyse des gemischten Poissonprozesses, gestützt auf Schadeneintrittszeitpunkte
-
Albrecht P (1982) Zur statistischen Analyse des gemischten Poissonprozesses, gestützt auf Schadeneintrittszeitpunkte. Blä Dtsch Ges Versich-math 15: 249-257.
-
(1982)
Blä Dtsch Ges Versich-Math
, vol.15
, pp. 249-257
-
-
Albrecht, P.1
-
2
-
-
77958471357
-
Differential expression analysis for sequence count data
-
Anders S, Huber W (2010) Differential expression analysis for sequence count data. Genome Biol 11: R106.
-
(2010)
Genome Biol
, vol.11
-
-
Anders, S.1
Huber, W.2
-
6
-
-
77953663084
-
Comparison of statistical approaches to evaluate factors associated with metabolic syndrome
-
Fekedulegn D, Andrew M, Violanti J, Hartley T, Charles L, Burchfiel C (2010) Comparison of statistical approaches to evaluate factors associated with metabolic syndrome. J Clin Hypertens 12: 365-373.
-
(2010)
J Clin Hypertens
, vol.12
, pp. 365-373
-
-
Fekedulegn, D.1
Andrew, M.2
Violanti, J.3
Hartley, T.4
Charles, L.5
Burchfiel, C.6
-
7
-
-
77951186070
-
On the extended Pólya process and some its interpretations
-
Ferreri C (1982) On the extended Pólya process and some its interpretations. Metron 41: 11-27.
-
(1982)
Metron
, vol.41
, pp. 11-27
-
-
Ferreri, C.1
-
8
-
-
0027192332
-
Estimating the variance of standardized rates of recurrent events, with application to hospitalizations among the elderly in New England
-
Glynn R, Stukel TA, Sharp SA, Bubolz A, Freeman JL, Fisher ES (1993) Estimating the variance of standardized rates of recurrent events, with application to hospitalizations among the elderly in New England. Am J Epidemiol 137: 776-786.
-
(1993)
Am J Epidemiol
, vol.137
, pp. 776-786
-
-
Glynn, R.1
Stukel, T.A.2
Sharp, S.A.3
Bubolz, A.4
Freeman, J.L.5
Fisher, E.S.6
-
12
-
-
0345601517
-
Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis
-
PRISMS (Prevention of Relapses and disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group
-
PRISMS (Prevention of Relapses and disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group (1998) Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. Lancet 352: 1498-1504.
-
(1998)
Lancet
, vol.352
, pp. 1498-1504
-
-
-
14
-
-
0033081690
-
Modelling MRI enhancing lesion counts in multiple sclerosis using a negative binomial model: implications for clinical trials
-
Sormani MP, Bruzzi P, Miller DH, Gasperini C, Barkhof F, Filippi M (1999) Modelling MRI enhancing lesion counts in multiple sclerosis using a negative binomial model: implications for clinical trials. J Neurol Sci 163: 74-80.
-
(1999)
J Neurol Sci
, vol.163
, pp. 74-80
-
-
Sormani, M.P.1
Bruzzi, P.2
Miller, D.H.3
Gasperini, C.4
Barkhof, F.5
Filippi, M.6
-
15
-
-
0034751645
-
Modelling new enhancing MRI lesion counts in multiple sclerosis
-
Sormani MP, Bruzzi P, Rovaris M, Barkhof F, Comi G, Miller DH, Cutter GR, Filippi M (2001a) Modelling new enhancing MRI lesion counts in multiple sclerosis. Mult Scler 7: 298-304.
-
(2001)
Mult Scler
, vol.7
, pp. 298-304
-
-
Sormani, M.P.1
Bruzzi, P.2
Rovaris, M.3
Barkhof, F.4
Comi, G.5
Miller, D.H.6
Cutter, G.R.7
Filippi, M.8
-
16
-
-
0035064704
-
Clinical trials of multiple sclerosis monitored with enhanced MRI: new sample size calculations based on large data sets
-
Sormani MP, Miller DH, Comi G, Barkhof F, Rovaris M, Bruzzi P, Filippi M (2001b) Clinical trials of multiple sclerosis monitored with enhanced MRI: new sample size calculations based on large data sets. J Neurol Neurosurg Psychiatry 70: 494-499.
-
(2001)
J Neurol Neurosurg Psychiatry
, vol.70
, pp. 494-499
-
-
Sormani, M.P.1
Miller, D.H.2
Comi, G.3
Barkhof, F.4
Rovaris, M.5
Bruzzi, P.6
Filippi, M.7
-
17
-
-
0035849496
-
Randomized controlled trial of interferon beta-1a in secondary progressive MS: clinical results
-
SPECTRIMS (Secondary Progressive Efficacy Clinical Trial of Recombinant Interferon beta-1a in MS) Study Group
-
SPECTRIMS (Secondary Progressive Efficacy Clinical Trial of Recombinant Interferon beta-1a in MS) Study Group (2001) Randomized controlled trial of interferon beta-1a in secondary progressive MS: clinical results. Neurology 56: 1496-1504.
-
(2001)
Neurology
, vol.56
, pp. 1496-1504
-
-
-
18
-
-
58149098225
-
The distribution of new enhancing lesion counts in multiple sclerosis: further explorations
-
Vanden Elskamp I, Knol D, Uitdehaag B, Barkhof F (2009) The distribution of new enhancing lesion counts in multiple sclerosis: further explorations. Mult Scler 15: 42-49.
-
(2009)
Mult Scler
, vol.15
, pp. 42-49
-
-
Vanden Elskamp, I.1
Knol, D.2
Uitdehaag, B.3
Barkhof, F.4
-
19
-
-
69549120685
-
Statistical methods for the analysis of relapse data in MS clinical trials
-
Wang YC, Meyerson L, Tang YQ, Qian N (2009) Statistical methods for the analysis of relapse data in MS clinical trials. J Neurol Sci 285: 206-211.
-
(2009)
J Neurol Sci
, vol.285
, pp. 206-211
-
-
Wang, Y.C.1
Meyerson, L.2
Tang, Y.Q.3
Qian, N.4
|